SCHEMBL2407451

SCHEMBL2407451

CCC(N)CB(Oc1ccccc1)c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA4 P22748 1/20 0.34
▸ SCN4A P35499 2/20 0.33
▸ MAOA P21397 1/20 0.32
▸ PTGS1 P23219 1/20 0.32
▸ LTA4H P09960 2/20 0.32
▸ EPHX1 P07099 1/20 0.31
▸ HTR2A P28223 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ TRPM2 O94759 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ ALOX12 P18054 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25772760 0.70 PCSK9 (0.50) CA4MAOALTA4HHTR2AALDH1A1
SCHEMBL5025922 0.68 SCN4A (0.57) SCN4AMAOAPTGS1LTA4HLMNA
SCHEMBL5286693 0.68 SCN4A (0.57) SCN4AMAOAPTGS1LTA4HLMNA
SCHEMBL27548575 0.68 SCN4A (0.57) SCN4AMAOAPTGS1LTA4HLMNA
SCHEMBL12270998 0.68 KDM4E (0.48) SCN4AMAOAEPHX1HTR2AKDM4E
SCHEMBL2408236 0.67 SMN1; SMN2 (0.34) HTR2AKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL5323614 0.66 TAAR1 (0.50) SCN4ALTA4HALDH1A1TDP1
SCHEMBL5280439 0.64 KCNA3 (0.54) SCN4ALTA4HALDH1A1TDP1
SCHEMBL1033247 0.63 SLC6A4 (0.43) CA4SCN4AMAOAPTGS1LTA4H
SCHEMBL7416230 0.62 KCNA3 (0.44) CA4LTA4HALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8853424-B2 Protein cross-linking inhibitor JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2014-10-07 — — US disclosed
US-20110212919-A1 PROTEIN CROSS-LINKING INHIBITOR JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2011-09-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212919-A1 PROTEIN CROSS-LINKING INHIBITOR BAZ2B, PRMT1, BRIX1 CA4 3624/4885SCN4A 2539/4885MAOA 2585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback